SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
longz
maceng2
To: combjelly who wrote (1562409)10/2/2025 9:59:05 PM
From: Maple MAGA 2 Recommendations  Read Replies (1) of 1576953
 
That’s simply false, and it displays an unrivalled level of ignorance on your part.

Traditional vaccines did undergo years of trials and real-world validation.
The polio vaccine, for instance, began human testing in 1952 and wasn’t licensed until 1955. after one of the largest randomized clinical trials in history, involving 1.8 million children. The measles vaccine went through field testing from 1958–1963 before approval, followed by years of surveillance and refinement. Tetanus toxoid was developed in the 1920s, tested through the 1930s, and became routine only in World War II after extensive follow-up. These weren’t “months of trials”; they were decades of refinement and longitudinal safety tracking before public rollout.

Viral genome type (DNA vs RNA) doesn’t excuse skipping long-term safety evaluation.
Yes, RNA viruses mutate faster, but that affects antigen matching, not the safety evaluation of the delivery platform. Each new flu vaccine isn’t a brand-new product starting from scratch; it’s an update to a platform that’s already been thoroughly validated over decades. Likewise, COVID mRNA vaccines used a novel platform that had never been mass-deployed before, so comparing them to annual flu-strain tweaks is scientifically misleading.

Regulatory history matters.
Historically, vaccines required multiple clinical phases, preclinical (animal), Phase 1 (safety), Phase 2 (dosing/efficacy), Phase 3 (large-scale randomized trials), and post-marketing surveillance, often spanning 5–15 years. Only emergency authorizations like those for COVID compressed that timeline by overlapping phases, which is exactly why long-term safety and durability data are still being accumulated after roll-out.

Calling that “stupid” isn’t an argument.
It’s an emotional deflection. The historical record is clear: traditional vaccines were built slowly, conservatively, and validated over long periods before becoming routine. That’s precisely why they earned enduring public trust, something the rushed pandemic roll-outs haven’t achieved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext